Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context

Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context

Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure i...

Full description

Bibliographic Details
Main Authors: Gwendolien Vanderschaeghe, Jolien Schaeverbeke, Rose Bruffaerts, Rik Vandenberghe, Kris Dierickx
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Alzheimer’s Research & Therapy
Subjects:
Ethics
Amnestic MCI
MCI due to AD
Research
Qualitative research
Disclosure
Online Access:http://link.springer.com/article/10.1186/s13195-017-0321-3

Internet

http://link.springer.com/article/10.1186/s13195-017-0321-3

Similar Items